<DOC>
	<DOC>NCT00241124</DOC>
	<brief_summary>A study comparing the antihypertensives Valsartan and Lisinporil when doses are in the morning and comparing a morning dose of Valsartan with an evening dose.</brief_summary>
	<brief_title>Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Hypertension defined by a MSSBP &gt;=150 mmHg (untreated patients) or patients on current antihypertensive treatment who remain uncontrolled (i.e. MSSBP &gt;140 mmHg) Randomisation mean 24h blood pressure above 130/80 mmHg In addition the patients must fulfill, at least, one of the following criteria: Controlled type II Diabetes mellitus Hypercholesteremia, currently treated with lipidlowering drugs Metabolic syndrome MI, CABG or PTCA more than one year ago Stroke or transient ischemic cerebral attack more than one year ago Documented history of peripheral vascular disease, increased IMT, or carotid plaques Documented history of LVH Elderly &gt;65 years MSSBP &gt;=180 mmHg and/or MSDBP &gt;= 110 mmHg at any time from Visit 1 to Visit 3 Inability to discontinue all prior antihypertensive medications safely for a period of three weeks Mandatory indication for any concomitant medication for coronary artery disease or any other disease that is not allowed during this study. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>valsartan</keyword>
	<keyword>morning/evening dosing</keyword>
	<keyword>lisinopril</keyword>
</DOC>